Canadian Biosimilars Industry Urges Ontario To Switch
Biosimilars Canada Once Again Calls On Province To Follow Example Of Others
Executive Summary
Biosimilars Canada has renewed its call for Ontario to adopt a biosimilar switching policy in line with other Canadian provinces and territories, suggesting that Ontario alone could save CAD147m annually through such a scheme.